UnitedHealth Group Inc. (NYSE: UNH) is a well-known health insurer, offering health care benefits to millions of clients, primarily in the U.S. UNH stock recently caught investors’ attention after the company delivered impressive profit and sales for the third quarter. Here’s why United Health stock is back in the spotlight with multiple Wallstreet institutions boosting their UNH stock valuations.…
Ocugen Inc (NASDAQ: OCGN) is a US based biopharmaceutical company which has primarily focused its research on developing a cure for blindness disease. However last year, Ocugen shifted their efforts towards distributing Covaxin, a COVID-19 vaccine developed by their Indian partner Bharat Biotech.…
Xenon Pharmaceuticals Inc (NASDAQ: XENE) stock has reached new heights after announcing promising trial results for its drug XEN1101 in the treatment for adult patients with focal epilepsy. The promising data rang bells on Wallstreet, with investors sending the stock 101.92% higher.…
Merck & Co. (NYSE: MRK) shares jumped more than 8% on Friday, after the company released an update regarding its experimental Covid-19 antiviral oral drug molnupiravir.
The interim analysis from the Phase 3 trial found Molnupiravir may prevent the chances of hospitalization or death from COVID-19 by 50% among people who are at high risk of infection.…
Ocugen Inc (NASDAQ: OCGN) is a US based bio-pharma which has primarily focused its research on developing a cure for blindness disease. In 2020, Ocugen shifted its efforts to distribute a COVID-19 vaccine with Indian partner Bharat Biotech. Ocugen’s CEO Shankar Musunuri made it clear that the company strategises to disrupt the current COVID-19 vaccine market with Covaxin.…
Soaring Eagle Acquisition Corp. (NASDAQ:SRNG) is set to merge with bio tech company Ginkgo Bioworks in a $15 Billion deal. The mammoth deal is expected to provide the biotech company $2.5 Billion in primary cash proceeds to fund future growth within multiple industries.…
To say Moderna (NASDAQ:MRNA) has had a brilliant year trading on Wallstreet would be an understatement. The COVID-19 vaccine candidate has provided investors immense returns over the past 12-18 months gaining 333% YTD.
Moderna’s strong revenue boost in 2021 has been derived from the overall depth of the COVID-19 vaccine market, which is expected to grow to $132.3 billion by 2025.…
Ocugen Inc (NASDAQ: OCGN) has been given a boost from Wallstreet this morning after Noble Financial analyst Robert LeBoyer initiated coverage with a Buy rating and a $15 price target. The price target suggests an upside of 114% from the current trading price.…
Cassava Sciences Inc (NASDAQ:SAVA) stock has experienced a strong bullish run over the past month, gaining 51%. Investors are awaiting Cassava’s clinical-trial data to be presented at the Alzheimer’s Association International Conference (AAIC) on July 29. The data is from Cassava’s leading candidate Sumifilam.…
Tempest Therapeutics (NASDAQ:TPST) is gaining momentum this week after H.C Wainwright listed a $51 price target on the stock. The stock is running strong after the completion of the Millendo Therapeutics merger. TPST has gained 108% over the past week of trading, which is driving large amounts of interest in the stock.…